Trisalus Life Sciences Inc (TLSI)

Nov 25, 2024

Trisalus life sciences director Wahlstrom Mats buys $22,750 in stock - Investing.com

Nov 25, 2024

Nov 25, 2024

Trisalus life sciences director Wahlstrom Mats buys $22,750 in stock By Investing.com - Investing.com UK

Nov 25, 2024

Nov 23, 2024

TriSalus Life Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 23, 2024

Nov 23, 2024

Trisalus life sciences director Mats Wahlstrom buys $47,056 in stock By Investing.com - Investing.com Australia

Nov 23, 2024

Nov 23, 2024

Trisalus life sciences director Mats Wahlstrom buys $47,056 in stock - Investing.com India

Nov 23, 2024

Nov 20, 2024

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Nov 20, 2024

Nov 19, 2024

Canaccord Genuity Group Lowers TriSalus Life Sciences (NASDAQ:TLSI) Price Target to $11.00 - Defense World

Nov 19, 2024

Nov 15, 2024

Canaccord cuts TriSalus shares target, keeps buy rating on Q3 report - Investing.com Canada

Nov 15, 2024

Nov 15, 2024

TriSalus Life Sciences (NASDAQ:TLSI) Given New $11.00 Price Target at Canaccord Genuity Group - MarketBeat

Nov 15, 2024

Nov 15, 2024

TriSalus Life Sciences Inc (TLSI) Quarterly 10-Q Report - Quartzy

Nov 15, 2024

Nov 15, 2024

MedTech Acquisition (OTCMKTS:MTACU) Files 8-K Report with SEC Announcement - Defense World

Nov 15, 2024

Nov 14, 2024

TriSalus Life Sciences Reports Strong Q3 Growth - TipRanks

Nov 14, 2024

Nov 14, 2024

TriSalus Reports Q3 2024 Financial Results and Provides Business Update - BioSpace

Nov 14, 2024

Nov 14, 2024

TriSalus Life Sciences Revenue Soars 42% in Q3, Expands into $375M Market | TLSI Stock News - StockTitan

Nov 14, 2024

Nov 13, 2024

TriSalus Life Sciences Inc (TLSI) Q3 2024 Earnings Report Previe - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

TriSalus Life Sciences Inc (TLSI) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance

Nov 13, 2024

Nov 13, 2024

Q3 Earnings Estimate for TLSI Issued By Roth Capital - MarketBeat

Nov 13, 2024

Nov 12, 2024

TriSalus Life Sciences (NASDAQ:TLSI) Upgraded by Roth Capital to "Strong-Buy" Rating - MarketBeat

Nov 12, 2024

Nov 11, 2024

Roth/MKM starts TriSalus shares coverage with Buy rating, $11 target By Investing.com - Investing.com South Africa

Nov 11, 2024

Nov 11, 2024

Roth/MKM starts TriSalus shares coverage with Buy rating, $11 target - Investing.com Canada

Nov 11, 2024

Nov 11, 2024

This GeoVax Labs Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Monday - Benzinga

Nov 11, 2024

Nov 11, 2024

TriSalus Life Sciences (NASDAQ:TLSI) Earns Buy Rating from Analysts at Roth Mkm - MarketBeat

Nov 11, 2024

Nov 11, 2024

Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav - Business Wire

Nov 11, 2024

Nov 08, 2024

Reviewing TriSalus Life Sciences (TLSI) and Its Peers - Defense World

Nov 08, 2024

Nov 08, 2024

Critical Comparison: CARGO Therapeutics (CRGX) and Its Rivals - Defense World

Nov 08, 2024

Nov 07, 2024

TriSalus Life Sciences Launches TriNav® LV Infusion System and TriGuide™ Guiding Catheters, Expanding Portfolio of PEDD™ Devices for Improved Tumor Treatment - BioSpace

Nov 07, 2024

Nov 07, 2024

TriSalus Life Sciences (TLSI) to Release Quarterly Earnings on Thursday - MarketBeat

Nov 07, 2024

Nov 07, 2024

TriSalus Life Sciences (TLSI) Set to Announce Earnings on Thursday - MarketBeat

Nov 07, 2024

Nov 07, 2024

TriSalus Life Sciences (TLSI) Set to Announce Quarterly Earnings on Thursday - Defense World

Nov 07, 2024

Nov 05, 2024

TriSalus Life Sciences® Inc. Launches TriNav® LV Infusion System and TriGuide? Guiding Catheters, Expanding Portfolio of PEDD? Devices for Improved Tumor Treatment - Marketscreener.com

Nov 05, 2024

Nov 04, 2024

TriSalus Life Sciences, Inc. Announces Resignation and Departure of Board Member and Chief Medical Officer - Defense World

Nov 04, 2024

Oct 31, 2024

TriSalus Life Sciences to Host Third Quarter 2024 Financial Results Conference Call - BioSpace

Oct 31, 2024

Oct 29, 2024

Northland Securities Begins Coverage on TriSalus Life Sciences (NASDAQ:TLSI) - Defense World

Oct 29, 2024

Oct 29, 2024

Intrahepatic Cholangiocarcinoma Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, and Key Companies involved by DelveInsight | Xencor, Relay Therapeutics, Kinnate Biopharma, Forma Therapy - Barchart

Oct 29, 2024

Oct 29, 2024

Intrahepatic Cholangiocarcinoma Pipeline Update 2024: FDA - openPR

Oct 29, 2024

Oct 28, 2024

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Short Interest Up 21.3% in October - MarketBeat

Oct 28, 2024

Oct 26, 2024

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat

Oct 26, 2024

Oct 26, 2024

Northland Capmk Upgrades TriSalus Life Sciences (NASDAQ:TLSI) to "Strong-Buy" - MarketBeat

Oct 26, 2024

Oct 25, 2024

Northland initiates TriSalus shares with outperform, cites sales growth - Investing.com India

Oct 25, 2024

Oct 25, 2024

Northland initiates TriSalus shares with outperform, cites sales growth By Investing.com - Investing.com South Africa

Oct 25, 2024

Oct 25, 2024

TriSalus Life Sciences (NASDAQ:TLSI) Coverage Initiated by Analysts at Northland Securities - MarketBeat

Oct 25, 2024

Oct 18, 2024

ALUS presents the 2024 Dave Reid Award to François Allard - GlobeNewswire Inc.

Oct 18, 2024

Oct 18, 2024

Riad Salem Joins Scientific Advisory Board Of TriSalus Life Sciences - MPO-mag

Oct 18, 2024

Oct 18, 2024

Riad Salem Joins Scientific Advisory Board of TriSalus Life Sciences - MPO-mag

Oct 18, 2024

Oct 15, 2024

TriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit - BioSpace

Oct 15, 2024

Oct 15, 2024

Interventional Approaches for Locally Advanced Pancreatic Cancer - HMP Global Learning Network

Oct 15, 2024

Oct 12, 2024

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Short Interest Up 62.5% in September - MarketBeat

Oct 12, 2024